REFERENCES
1. Wallace A, Richards GM, Harari PM, Kirwan JM, Morris CG, Katakam H, et al. Head and neck squamous cell carcinoma from an unknown primary site. Am J Otolaryngol. 2011 Jul;32(4):286–90.
2. Hobbs CGL, Sterne JAC, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol Off J ENT-UK ; Off J Netherlands Soc Oto-Rhino-Laryngology Cerv-fac Surg. 2006 Aug;31(4):259–66.
3. Zanoni DK, Patel SG, Shah JP. Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: Rationale and Implications. Curr Oncol Rep. 2019 Apr;21(6):52.
4. Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer–systematic review and meta-analysis of trends by time and region. Head Neck. 2013 May;35(5):747–55.
5. Owadally W, Hurt C, Timmins H, Parsons E, Townsend S, Patterson J, et al. PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer. 2015 Aug;15:602.
6. Ferris RL, Flamand Y, Weinstein GS, Li S, Quon H, Mehra R, et al. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311). J Clin Oncol Off J Am Soc Clin Oncol. 2021 Oct;JCO2101752.
7. Mackenzie K, Watson M, Jankowska P, Bhide S, Simo R. Investigation and management of the unknown primary with metastatic neck disease: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016/05/12. 2016;130(S2):S170–5.
8. Maghami E, Ismaila N, Alvarez A, Chernock R, Duvvuri U, Geiger J, et al. Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline. J Clin Oncol. 2020;38(22):2570–96.
9. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Head and Neck Cancers. 2021.
10. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009 Jul;339:b2700.
11. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003 Sep;73(9):712–6.
12. Abu-Shama Y, Salleron J, Carsuzaa F, Sun X-S, Pflumio C, Troussier I, et al. Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary. Cancers (Basel). 2021 May;13(10).
13. Cho WK, Roh J-L, Cho K-J, Choi S-H, Nam SY, Kim SY. Predictors of survival and recurrence after primary surgery for cervical metastasis of unknown primary. J Cancer Res Clin Oncol. 2020 Apr;146(4):925–33.
14. Dragan AD, Nixon IJ, Guerrero-Urbano MT, Oakley R, Jeannon J-P, Simo R. Selective neck dissection as a therapeutic option in management of squamous cell carcinoma of unknown primary. Eur Arch oto-rhino-laryngology Off J Eur Fed Oto-Rhino-Laryngological Soc Affil with Ger Soc Oto-Rhino-Laryngology - Head Neck Surg. 2014 May;271(5):1249–56.
15. Eisbruch A, Koukourakis G V, Gutfeld O, Prince ME, Bradford CR, Wolf GT, et al. Head and neck squamous cell carcinoma of unknown primary: Neck dissection and radiotherapy or definitive radiotherapy. Head Neck. 2013;
16. Keller LM, Galloway TJ, Holdbrook T, Flieder DB, Ruth K, Lango MN, et al. P16 Status, pathologic and clinical characteristics, and long-term outcomes in unknown primary carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2012;84(3 SUPPL. 1):S514.
17. Santa Maria PL, Sader C, Preston NJM, Fisher PH. Neck dissection for squamous cell carcinoma of the head and neck. Otolaryngol neck Surg Off J Am Acad Otolaryngol Neck Surg. 2007 Apr;136(4 Suppl):S41-5.
18. Guntinas-Lichius O, Peter Klussmann J, Dinh S, Dinh M, Schmidt M, Semrau R, et al. Diagnostic work-up and outcome of cervical metastases from an unknown primary. Acta Otolaryngol. 2006 May;126(5):536–44.
19. Boscolo-Rizzo P, Da Mosto MC, Gava A, Marchiori C. Cervical lymph node metastases from occult squamous cell carcinoma: analysis of 82 cases. ORL J Otorhinolaryngol Relat Spec. 2006;68(4):189–94.
20. Yalin Y, Pingzhang T, Smith GI, Ilankovan V. Management and outcome of cervical lymph node metastases of unknown primary sites: a retrospective study. Br J Oral Maxillofac Surg. 2002 Dec;40(6):484–7.
21. Hatten KM, O’Malley BWJ, Bur AM, Patel MR, Rassekh CH, Newman JG, et al. Transoral Robotic Surgery-Assisted Endoscopy With Primary Site Detection and Treatment in Occult Mucosal Primaries. JAMA Otolaryngol Head Neck Surg. 2017 Mar;143(3):267–73.
22. Al Kadah B, Papaspyrou G, Linxweiler M, Schick B, Rübe C, Büchler BS, et al. Cancer of unknown primary (CUP) of the head and neck: retrospective analysis of 81 patients. Eur Arch oto-rhino-laryngology Off J Eur Fed Oto-Rhino-Laryngological Soc Affil with Ger Soc Oto-Rhino-Laryngology - Head Neck Surg. 2017 Jun;274(6):2557–66.
23. Amsbaugh MJ, Yusuf M, Gaskins J, Silverman C, Potts K, Bumpous J, et al. Neck dissection for unknown cancer of the head and neck in the era of chemoradiation. Am J Otolaryngol. 2017;38(5):588–92.
24. Hu KS, Mourad WF, Gamez ME, Lin W, Jacobson AS, Persky MS, et al. Five-year outcomes of an oropharynx-directed treatment approach for unknown primary of the head and neck. Oral Oncol. 2017 Jul;70:14–22.
25. Patel SA, Parvathaneni A, Parvathaneni U, Houlton JJ, Karni RJ, Liao JJ, et al. Post-operative therapy following transoral robotic surgery for unknown primary cancers of the head and neck. Oral Oncol. 2017 Sep;72:150–6.
26. Kharytaniuk N, Molony P, Boyle S, O’Leary G, Werner R, Heffron C, et al. Association of Extracapsular Spread With Survival According to Human Papillomavirus Status in Oropharynx Squamous Cell Carcinoma and Carcinoma of Unknown Primary Site. JAMA Otolaryngol Head Neck Surg. 2016 Jul;142(7):683–90.
27. Graboyes EM, Sinha P, Thorstad WL, Rich JT, Haughey BH. Management of human papillomavirus-related unknown primaries of the head and neck with a transoral surgical approach. Head Neck. 2015 Nov;37(11):1603–11.
28. Demiroz C, Vainshtein JM, Koukourakis G V, Gutfeld O, Prince ME, Bradford CR, et al. Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy. Head Neck. 2014 Nov;36(11):1589–95.
29. Marinov V, Rangachev J, Popov G. Cervical lymph node metastasis from an unknown primary site. Laryngorhinootologie. 2019;98(Supplement 2):S264–5.
30. Amsbaugh MJ, Perez CA, Gaskins J, Silverman CL, Bumpous J, Potts K, et al. Squamous cell cancer of an unknown primary head and neck site: Is upfront neck dissection still relevant in the era of chemoradiation? Int J Radiat Oncol Biol Phys. 2016;94(4):894.
31. Colbert S, Algholmy M, Gray M, Walji S, Davies J. Management of the cervical lymph node metastasis of unknown origin. Br J Oral Maxillofac Surg. 2011;49(SUPPL. 1):S43.
32. Kar A, Eichholz A, Sarkodie T, Simo R, O’Connell MEA. Metastatic squamous cell carcinoma of head & neck of unknown primaryorig in treated by neck dissection and pan-mucosal post-operative radiotherapy (PORT): outcomes, toxicity and prognostic factors. Radiother Oncol. 2010;96:S323‐.
33. Matsuzuka T, Kano M, Sato H, Suzuki M, Ozawa K. Therapy unknown cervical metastasis from unknown primary sites. Oto-Rhino-Laryngology Tokyo. 2003;46(SUPPL. 2):62–7.
34. Sato N, Kuwashima S, Sato H, Murai K. Analysis of cervical metastatic carcinomas from unknown primary tumors. Oto-Rhino-Laryngology Tokyo. 2003;46(SUPPL. 2):44–8.
35. Kadokura Y, Yanagi Y, Kubota T, Matsui K, Takemura H, Nagase D. Clinical analysis of metastatic cancer from unknown primary sites. Pract Otol Suppl. 2002;(109):167–71.
36. Cappello ZJ, Eid M, Cash E, Tennant P, Potts K, Wilson L, et al. Prognostic indications of p16 and smoking status in predicting the need for posttreatment neck dissection after chemoradiation therapy in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2016;94(4):908–9.
37. Silva JP, Alexandre MT, Ferreira D, Sargento I, Ferreira M, Moreira A, et al. Cercival lymph node metastasis of squamous cell carcinoma of an unknown primary (SCCUP): A single institutional review. Ann Oncol. 2016;27(Supplement 6).
38. Amsbaugh MJ, Silverman CL, Bumpous J, Potts K, Perez C, Bert R, et al. Upfront neck dissection in the era of chemoradiation for head and neck squamous cell carcinoma of unknown primary site. Int J Radiat Oncol Biol Phys. 2015;93(3 SUPPL. 1):E324.
39. Nguyen N, Hodson D, Doerwald-Munoz LE, Jim W, Zhang H. Head and neck squamous cell carcinoma of unknown primary: Is there a better treatment? Int J Radiat Oncol Biol Phys. 2014;90(1 SUPPL. 1):S570.
40. Berta E, Reyt E, Atallah I, Righini CA, Quesada JL, Villa J, et al. Treatmentof head and neck squamous cell carcinoma of an unknown primary (HNCCUP): Oncologic analysis of 35 cases. Rev Laryngol Otol Rhinol. 2013;134(3):131–8.
41. Kobayashi K, Omura G, Saito Y, Ebihara Y, Asakage T, Yamasoba T. Prognostic factors in recent head and neck squamous cell carcinoma of unknown primary site (HNSCCUP). Otolaryngol - Head Neck Surg (United States). 2013;149(2 SUPPL. 1):P187.
42. Straetmans J, Lacko M, Mujagic Z, Kremer B, Speel E-J, Vent J, et al. Differenc es in managem ent of neck metastases of unknown primary origin in two european centres: Conseque nces for future strategies. Oral Oncol. 2013;49(SUPPL. 1):S54.
43. Simo R, Dragan A, Nixon I, Guerrero-Urbano MT, Oakley R, Jeannon J-P. Patterns of neck metastases in patients presenting with cervical squamous cell carcinoma of unknown origin X. Eur Arch Oto-Rhino-Laryngology. 2012;269(4):1358–9.
44. Lou J, Guo L, Zhao J, Wang S. [Squamous cell carcinoma of cervical lymph nodes from an unknown primary site: a retrospective analysis of treatment strategies and prognosis]. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese J Otorhinolaryngol head neck Surg. 2013 Jan;48(1):32–6.
45. Tagawa T, Tomita T, Yamaguchi H, Ozawa H, Sakamoto K, Ogawa K, et al. [Clinical study of 28 cases of cervical lymph node metastasis from an unknown primary carcinoma]. Nihon Jibiinkoka Gakkai Kaiho. 2007 Jul;110(7):506–12.
46. Ijichi K, Hasegawa Y, Ogawa T, Terada A, Hyodo I, Yamada H, et al. [Investigation for cervical lymph node metastasis in unknown primary sites]. Nihon Jibiinkoka Gakkai Kaiho. 2005 Nov;108(11):1083–90.
47. Watanabe F, Yamamoto E, Shiomi Y, Tanabe M, Fujiwara K, Kikuchi M. Cervical lymph node metastasis from an unknown primary tumor. Pract Otorhinolaryngol (Basel). 2003;96(4):361–4.
48. Koscielny S, Gudziol H, Kretzschmar J. Cervical lymph nodes of unknown primary. Laryngorhinootologie. 2000;79(8):483–9.
49. Klop WM, Balm AJ, Keus RB, Hilgers FJ, Tan IB. [Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98]. Ned Tijdschr Geneeskd. 2000 Jul;144(28):1355–60.
50. Wichmann G, Willner M, Kuhnt T, Kluge R, Gradistanac T, Wald T, et al. Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of Neck Squamous Cell Carcinoma of Unknown Primary Patients. Front Oncol. 2021;11:682088.
51. Cummings MA, Ma SJ, Van Der Sloot P, Milano MT, Singh DP, Singh AK. Squamous cell carcinoma of the head and neck with unknown primary: trends and outcomes from a hospital-based registry. Ann Transl Med. 2021 Feb;9(4):284.
52. Rödel RMW, Matthias C, Blomeyer BD, Wolff HA, Jung K, Christiansen H. Impact of distant metastasis in patients with cervical lymph node metastases from cancer of an unknown primary site. Ann Otol Rhinol Laryngol. 2009 Sep;118(9):662–9.
53. Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck. 2008 Jan;30(1):28–34.
54. Patel RS, Clark J, Wyten R, Gao K, O’Brien CJ. Squamous cell carcinoma from an unknown head and neck primary site: a “selective treatment” approach. Arch Otolaryngol Head Neck Surg. 2007 Dec;133(12):1282–7.
55. Iganej S, Kagan R, Anderson P, Rao A, Tome M, Wang R, et al. Metastatic squamous cell carcinoma of the neck from an unknown primary: management options and patterns of relapse. Head Neck. 2002 Mar;24(3):236–46.
56. Dorobisz K, Wlodarska-Polinska I, Pazdro-Zastawny K, Rutkowski T, Palka P, Dworzecki T, et al. The impact of the patient’s condition, diagnostic procedures and treatment on the survival of carcinoma of unknown primary site patients. Cancer Manag Res. 2019;11:6603–14.
57. Zhou MJ, van Zante A, Lazar AA, Groppo ER, Garsa AA, Ryan WR, et al. Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer. Head Neck. 2018 May;40(5):904–16.
58. Mizuta M, Kitamura M, Tateya I, Tamaki H, Tanaka S, Asato R, et al. Unknown primary squamous cell carcinoma of the head and neck: retrospective analysis of 80 cases. Acta Otolaryngol. 2018 Jun;138(6):590–6.
59. Hung Y-H, Liu S-A, Wang C-C, Wang C-P, Jiang R-S, Wu S-H. Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck. PLoS One. 2018;13(10):e0205365.
60. Axelsson L, Nyman J, Haugen-Cange H, Bove M, Johansson L, De Lara S, et al. Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection. J Otolaryngol - head neck Surg = Le J d’oto-rhino-laryngologie Chir cervico-faciale. 2017 Jun;46(1):45.
61. Dou S, Qian W, Ji Q, Wang Z, Zhu G. Tailored multimodality therapy guided by a two-step decision making process for head-and-neck cancer of unknown primary. Oncotarget. 2016 Jun;7(26):40095–105.
62. Lou J, Wang S, Wang K, Chen C, Zhao J, Guo L. Squamous cell carcinoma of cervical lymph nodes from an unknown primary site: The impact of neck dissection. J Cancer Res Ther. 2015 Oct;11 Suppl 2:C161-7.
63. Wongsritrang K, Fueangkamloon S. Clinical outcomes of cervical node metastasis from an unknown primary in Songklanagarind Hospital. J Med Assoc Thai. 2012 Sep;95(9):1200–4.
64. Axelsson L, Holmberg E, Nyman J, Hogmo A, Sjodin H, Gebre-Medhin M, et al. Swedish national multicenter study on head and neck cancer of unknown primary: prognostic factors and impact of treatment on survival. Int Arch Otorhinolaryngol. 2020;
65. Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet (London, England). 2019 Jul;394(10192):64–80.
66. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010 Jul;363(1):24–35.